Can You Get Giant Cell Arteritis Under Age 50?
At a Glance
Getting Giant Cell Arteritis (GCA) under age 50 is exceptionally rare. Medical guidelines define 50 as the strict minimum age for diagnosis. If you are younger and have symptoms of large blood vessel inflammation, doctors will likely evaluate you for a condition called Takayasu arteritis instead.
In this answer
2 sections
While navigating unexplained symptoms can be incredibly stressful, getting Giant Cell Arteritis (GCA) before the age of 50 is exceptionally rare. Medical literature and international diagnostic criteria typically define 50 as the strict minimum age threshold for a GCA diagnosis [1][2]. GCA predominantly affects older adults, with the average age of onset falling in the early to mid-70s, and the highest incidence occurring between ages 70 and 79 [1][3]. If you are in your 40s or younger and experiencing symptoms that resemble GCA, it is highly likely that a different underlying condition is responsible.
⚠️ URGENT MEDICAL WARNING: Regardless of your age or the underlying cause, if you are experiencing sudden vision changes (such as blurriness, double vision, or temporary loss of sight), seek emergency medical care immediately. Vision loss related to large-vessel inflammation can become permanent and irreversible within hours or days if not treated promptly. Doctors will often start emergency treatment, such as high-dose steroids, immediately to protect your eyesight, even before diagnostic tests are completed.
What Else Could Be Causing Your Symptoms?
When a person under 50 experiences symptoms of large-vessel inflammation—such as unexplained headaches, scalp tenderness, jaw pain, or limb pain—specialists will typically investigate other forms of vasculitis (blood vessel inflammation) before considering GCA [4].
The most common alternative diagnosis investigated in younger adults is Takayasu arteritis [5].
Takayasu Arteritis vs. GCA
Takayasu arteritis (TAK) is a form of large-vessel vasculitis that shares many clinical and pathological features with GCA, including inflammation of the aorta and its major branches [5][6]. The most significant difference between the two is the age at which they occur: while GCA targets adults over 50, TAK characteristically affects patients under 40 or 50 [7][6].
Because both diseases cause granulomatous inflammation (a specific type of immune system clustering in the blood vessels), they can sometimes feel identical to the patient [8]. However, doctors recognize them as clinically distinct diseases with different age demographics and slightly different patterns of vessel involvement [9][6].
For example, TAK may present with diminished or absent pulses, or noticeable differences in blood pressure between your two arms—often earning it the nickname “pulseless disease.” Stroke presentations also differ, with TAK more commonly involving the carotid arteries in the neck rather than the vessels supplying the back of the brain [10].
Other Potential Causes
Doctors evaluating a younger adult for vascular inflammation will also rule out:
- Other types of vasculitis: Such as Behçet’s syndrome (a rare disorder causing blood vessel inflammation throughout the body), which can also affect large blood vessels [11].
- Direct Infections (Infectious Aortitis): Bacterial or fungal infections that directly attack the blood vessel walls [12].
- Post-Viral Inflammation: Immune-mediated inflammation triggered by viruses like COVID-19, which causes a different type of vascular response than a direct bacterial infection [13].
How Doctors Diagnose Vascular Inflammation in Younger Patients
Because the differential diagnosis (the list of possible conditions) for medium-to-large-vessel vasculitis in young adults is broad, a comprehensive evaluation is critical [4].
If your care team suspects large-vessel inflammation, they will rely heavily on advanced diagnostic imaging techniques. Scans such as Magnetic Resonance Angiography (MRA), CT angiography, and 18F-FDG PET scans (which use a safe radioactive sugar tracer to light up areas of active inflammation in the body) are essential for making an accurate diagnosis [14][15][16].
While a temporal artery biopsy (taking a tiny physical sample of the artery near your temple) is the standard diagnostic tool for GCA in older adults, biopsies are rarely performed for Takayasu arteritis. This is because TAK typically affects deep vessels like the aorta and its main branches inside the chest and abdomen, making a surgical biopsy highly invasive and dangerous. Because of this, imaging scans are the cornerstone of diagnosis for younger patients.
A Note of Reassurance: While the diagnostic process can feel overwhelming and frightening, both Takayasu arteritis and other forms of large-vessel vasculitis are highly treatable conditions. With prompt, proper medical care and the right medical team, vascular inflammation can be managed effectively.
Common questions in this guide
Can I be diagnosed with Giant Cell Arteritis if I am under 50?
What else could cause GCA symptoms in younger adults?
How is Takayasu arteritis different from Giant Cell Arteritis?
How do doctors diagnose large-vessel vasculitis in younger patients?
Should I wait for test results before starting treatment for suspected vasculitis?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given my age and symptoms, are you evaluating me for Takayasu arteritis alongside or instead of Giant Cell Arteritis?
- 2.Should we start protective treatments, like steroids, while we wait for my imaging or biopsy results?
- 3.Do you recommend advanced imaging, like an MRA or PET scan, to see if my larger blood vessels are affected?
- 4.Are there specific blood pressure or pulse checks we should be monitoring between my arms?
- 5.Could a recent viral infection or another systemic issue be causing this inflammation?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (16)
- 1
Risk Factors and Pharmacological Interventions Impacting Cerebrovascular Ischemic Events in Giant Cell Arteritis: A Narrative Review.
Siddiqui MO, Syed MA, Qureshi AA, et al.
Immunity, inflammation and disease 2025; (13(1)):e70122 doi:10.1002/iid3.70122.
PMID: 39817601 - 2
Giant Cell Arteritis and Polymyalgia Rheumatica: 2016 Update.
Nesher G, Breuer GS
Rambam Maimonides medical journal 2016; (7(4)) doi:10.5041/RMMJ.10262.
PMID: 27824543 - 3
Every minute blinds: Temporal artery ultrasound in the real-time diagnosis of stroke of the eye.
Avasarala J, Gangadhara S, Bobadilla J, Chadha R
The American journal of emergency medicine 2026; (99()):97-101 doi:10.1016/j.ajem.2025.09.027.
PMID: 41004929 - 4
Spectrum of Large- and Medium-Vessel Vasculitis in Adults: Neoplastic, Infectious, Drug-Induced, Autoinflammatory, and Primary Immunodeficiency Diseases.
Lötscher F, Pop R, Seitz P, et al.
Current rheumatology reports 2022; (24(10)):293-309 doi:10.1007/s11926-022-01083-5.
PMID: 35920952 - 5
Recent advances in the diagnosis and therapy of large vessel vasculitis.
Keser G, Atagunduz P, Soy M
Polish archives of internal medicine 2022; (132(6)) doi:10.20452/pamw.16272.
PMID: 35699647 - 6
Takayasu arteritis: A distinct syndrome of large vessel vasculitis: A view point by late Professor Paul Bacon.
Misra R
International journal of rheumatic diseases 2019; (22 Suppl 1()):49-52 doi:10.1111/1756-185X.13383.
PMID: 30698354 - 7
The role of autoimmunity and autoinflammation in giant cell arteritis: A systematic literature review.
Schäfer VS, Brossart P, Warrington KJ, et al.
Autoimmunity reviews 2023; (22(6)):103328 doi:10.1016/j.autrev.2023.103328.
PMID: 36990133 - 8
Aortitis and aortic aneurysm in systemic vasculitis.
Tyagi S, Safal S, Tyagi D
Indian journal of thoracic and cardiovascular surgery 2019; (35(Suppl 2)):47-56 doi:10.1007/s12055-019-00832-z.
PMID: 33061066 - 9
Classification of large vessel vasculitis: Can we separate giant cell arteritis from Takayasu arteritis?
Koster MJ, Warrington KJ
Presse medicale (Paris, France : 1983) 2017; (46(7-8 Pt 2)):e205-e213 doi:10.1016/j.lpm.2016.11.032.
PMID: 28774474 - 10
Stroke characteristics in giant cell arteritis and Takayasu arteritis: A multicenter retrospective cohort study of 108 patients.
Dhrif O, Caudron C, Parreau S, et al.
Seminars in arthritis and rheumatism 2026; (77()):152943 doi:10.1016/j.semarthrit.2026.152943.
PMID: 41702324 - 11
Thrombosis in vasculitis: An updated review of etiology, pathophysiology, and treatment.
Zhu K, Lv F, Hou X, et al.
Heliyon 2024; (10(12)):e30615 doi:10.1016/j.heliyon.2024.e30615.
PMID: 38975109 - 12
Aortitis Presenting as Fever of Unknown Origin.
Yuan SM, Lin H
Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 2018; (24(6)):279-287 doi:10.5761/atcs.ra.18-00136.
PMID: 30158332 - 13
COVID-19-associated large-vessel vasculitis with elevated anti-angiotensin converting enzyme 2 antibody: three cases and a review of the literature.
Oyama S, Matsunaga A, Teratake Y, et al.
Clinical rheumatology 2026; (45(2)):1581-1588 doi:10.1007/s10067-025-07857-3.
PMID: 41351657 - 14
Magnetic resonance angiography versus 18F-fluorodeoxyglucose positron emission tomography in large vessel vasculitis.
Blockmans D, Luqmani R, Spaggiari L, Salvarani C
Autoimmunity reviews 2019; (18(12)):102405 doi:10.1016/j.autrev.2019.102405.
PMID: 31648043 - 15
Diagnostic Approaches for Large Vessel Vasculitides.
Betrains A, Blockmans D
Open access rheumatology : research and reviews 2021; (13()):153-165 doi:10.2147/OARRR.S282605.
PMID: 34113183 - 16
Multimodality imaging to assess diagnosis and evaluate complications of large vesselarteritis.
Aghayev A, Weber B, Lins de Carvalho T, et al.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2024; (37()):101864 doi:10.1016/j.nuclcard.2024.101864.
PMID: 38663459
This page is for informational purposes only and does not replace professional medical advice. If you experience sudden vision changes, seek emergency medical care immediately to prevent permanent damage.
Get notified when new evidence is published on Giant cell arteritis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.